Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > Tweet Blowback
View:
Post by Pareto8020 on Feb 10, 2021 10:08am

Tweet Blowback

If Sirona doesn't release some news soon they are just going to be completed torched every time they tweet.  They are already getting slammed on Twitter so if they don't deliver soon it is just going to get uglier and uglier..... and rightly so.  If Howard comes out and says they can't announce anything again because the company they are dealing won't let them I think every investors head will explode.... and we should then vote his buttocks out of the CEO chair at AGM.

 
Micha Molzberger
@MichaMolzberger
·
Feb 9
Replying to 
@SironaBiochem
Hard to  money without  product
Daccord
@Daccord2020
·
23h
Replying to 
@SironaBiochem
Yeah, you are starting to look like Peter, the one with the wolf syndrome, I’m afraid the day you finally come out with a product , nobody listens anymore.
Peter Germershausen
@DynamoGermi80
·
Feb 9
Replying to 
@SironaBiochem
So we need some deals and partnerships for our component. Flexed biceps
.
@TW8810
·
Feb 9
And a product. Until then everything is just bla bla bla
K Clifford
@KCliffo01982271
·
Feb 9
Replying to 
@SironaBiochem
Hangry for 1067? Rodan and Fields will be the first place to go for this product, we all can’t wait, really.
George
@George89986161
·
Feb 9
What if they never use it?
K Clifford
@KCliffo01982271
·
23h
Well if that was the case, Sirona would tell us.  But I think we are in good hands here.
George
@George89986161
·
23h
Yeah, sure they would.
 
KaiUweSkywalker
@SkywalkerUwe
·
18h
Replying to 
@SironaBiochem
„As a sirona shareholder, u wouldn’t believe how many messages I read on forums about other frustrated shareholder of this company“
George
@George89986161
·
Feb 9
Replying to 
@SironaBiochem
Such a huge market, and yet we can't sign any buyers except Rodan and Fields, who seem to have no interest in selling it? Is there a problem with 1067?
John Knig
@JohnKnig2
·
Feb 9
Guten Tag , warum hat denn ein Pharmaunternehmen die jetzige klinische Studie zum Hautaufheller TF-1067 untersttzt ?
Bestimmt nicht aus Nchstenliebe sondern weil es vermutlich Interesse an diesem Hautaufheller hat.Smiling face with sunglasses
George
@George89986161
·
Feb 9
We can only hope. I have been hoping for years.
 
Comment by lscfa on Feb 10, 2021 10:12am
If I had a Twitter account I would ask Sirona to add a patent expiry countdown clock to website.
Comment by MirrorWorldMan on Feb 10, 2021 11:38am
Tweets are just echoing what has been stated on this board for years by investors. The difference is that the readership base has become wider, and these potential customers are reading the criticisms now. Which may have the opposite effect to what Howie and his pow wow intends. Howie cannot shake his poor record at tangible accomplishments or slower than snail pace to do anything. He did not ...more  
Comment by pointer on Feb 10, 2021 10:25am
This post has been removed in accordance with Community Policy
Comment by lscfa on Feb 10, 2021 1:44pm
Can't they post pumps on Twitter and block replies?
Comment by biorun on Feb 10, 2021 2:22pm
They seem to be letting the conversation ride. Whatever. This is not an Elon interest. I watch this board. Emotive, and that is a curse for some, maybe many. Nice recovery from 19 cents last fall. Double. I am in and out often. Made some good coin.  Right now I am looking at a few key things with what this management is doing, done some independent diligence, and the fundamentals ...more  
Comment by pointer on Feb 10, 2021 3:15pm
This post has been removed in accordance with Community Policy
Comment by wexworth on Feb 10, 2021 5:47pm
My own research helps me make a decision. The pursuit is to get to the truth without emotion. I don't have access to anything special, I just do a lot of it, I am very thorough, and its mine. Sorry. You don't need it, and neither does anyone else here. The obvious is staring you in the face. The company is behaving quite differently lately.  Scrape away empty promises. Scrape away ...more  
Comment by biorun on Feb 10, 2021 7:40pm
What I have to share you probably already know. Not sure it would matter anyhow as it appears there are two camps - one that is rose glasses and another that doesn't believe anything management communicates.  I just think we are letting this all cloud judgment to a certain extent, at this particular moment - perhaps for next 8 weeks.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities